Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • RGTI vs GSK✓SelectedUSD · GSKRGTI vs GSK performance historyLatest closeAs of-11.17%11/20
Stock and ETF performance explorer

RGTI vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-38.4%
GSK return
+40.7%
Excess return
-79.0%
Maximum drawdown
-96.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-11.2%-0.1%-11.0%-11.1%
7D-25.6%-5.3%-20.2%-24.8%
30D-40.6%-3.7%-36.9%-40.1%
3M-55.4%-7.3%-48.2%-54.8%
6M-57.6%-4.2%-53.3%-57.4%
YTD-67.7%+0.9%-68.5%-68.1%
1Y-68.6%+7.3%-75.9%-69.6%
3Y+581.9%+52.7%+529.2%+480.9%
All-38.4%+40.7%-79.0%-52.9%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling